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Background: Fractional Flow Reserve (FFR), a measure of coronary stenosis severity is based
on the achievement of maximal hyperemia of coronary microcirculation. The most widely
used pharmacological agent is adenosine which is administered either by intra coronary or
intra venous routes. IV route is time consuming, has more side effects and expensive. This
study is undertaken to compare the two routes of administration.
Methods: FFR was assessed in 50 patients with 56 intermediate focal lesions using both IV
and intracoronary (IC) adenosine. FFR was calculated as the ratio of the distal coronary
pressure to the aortic pressure at maximal hyperemia.
Results: A total of 25 left anterior descending, 8 right, 21 circumflex, and 2 left main coro-
nary arteries were evaluated. The mean percent stenosis was 63.91  13.13 SD and, the
mean FFR was 0.831  0.0738 SD for IV and 0.832  0.0707 SD for IC adenosine. There was a
strong and linear correlation between 2 sets of observations with IV dose and IC adenosine
dose (R ¼ 0.964, y ¼ 0.065 þ 0.923x; p < 0.001) (y ¼ IV dose, x ¼ IC dose). The agreement
between the two sets of measurements was also high, with a mean difference of:
0.001  0.0197. The changes in heart rate and blood pressure were significantly higher in IV
adenosine group. Different incremental doses were well tolerated, with fewer systemic
adverse events with IC adenosine. Transient AV blocks were observed with both IV and IC
adenosine.
Conclusions: This study suggests that IC adenosine is equivalent to IV infusion for the
determination of FFR. The administration of IC adenosine is easy to use, cost effective, safe
and associated with fewer systemic events.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction cardiac imaging, CAG continues to remain the gold standardThe temporal and spatial resolution of coronary angiography
(CAG) havemeant that despitemajor advances in noninvasive(U. Kaul).
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However, the 2-dimensional silhouette image provided by
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morphology, and gives no indication of the functional influ-
ence of luminal changes on coronary blood flow. These limi-
tations aremore pronounced in angiographically intermediate
stenosis (50e90%) and in patients in whom there is a clear
discrepancy between the clinical picture and angiographic
findings.1e4
The measurement of Fractional Flow Reserve (FFR) is used
to determine the hemodynamic significance of epicardial
coronary stenosis detected at CAG.3 For an accurate calcula-
tion of FFR, the principle is to achieve amaximal hyperemia to
minimize the contribution of microvascular resistance.5 With
suboptimal levels of coronary hyperemia, FFR will be artifi-
cially high, resulting in a potentially significant underesti-
mation of the functional severity of the coronary stenosis.
This physiologic method of assessing the severity of coronary
lesions has become a very acceptable simple method utilized
in a large numbers of cardiac catheterization laboratories
world over after the results of FAME study were published.4,5
The method is being utilized in our country also increas-
ingly. We have previously demonstrated its utility and cost
saving advantage in our set.6
Although adenosine invariably intravenously (IV), has been
recommended for FFR measurements, intracoronary (IC)
administration of adenosine constitutes a valuable alternative
in everyday practice.4e9 Compared with the IC route, IV
adenosine administration requires relatively large doses, and
it is associated with more systemic adverse effects and
costs.10,11 However, several observations cast some doubts
about the ability of the IC adenosine boluses to achieve
maximal hyperemia in all patients.11,12
The aim of this study was to compare IV versus IC adeno-
sine for calculating an accurate FFR at maximal hyperemia by
two methods. The FFR was calculated by both methods in our
setting at maximum hyperemia.Table 1 e Baseline demographic data of the study
population.
Study cohort (50 patients, 56 lesions)
Age (yr.) 62  8
Male/Female 36/14
Risk factors
Hypertension 18 (36%)
Diabetes 21 (42%)
Smoking 10 (20%)
Dyslipidemia 15 (30%)
Old MI 5 (10%)
Angiographic parameters
Single vessel disease 13 (26%)
Double vessel disease 26 (52%)
Triple vessel disease 11 (22%)
Percent stenosis (%) 63.9  13.1
Target vessel
LAD 25 (44.6%)
LCX 21 (37.5%)
RCA 8 (14.3%)
LM 2 (3.6%)
Ejection fraction (%) 55  5%
LAD, Left anterior descending artery; RCA, right coronary artery;
LCx, left circumflex artery; LM, left main coronary artery.2. Methods
2.1. Study population
FFR was assessed in a total of 50 patients enrolled prospec-
tively. The study population consisted of 36 males and 14 fe-
males with a mean age of 62  8 years. Most patients had
normal left ventricular function, and only focal or short
segment of coronary artery stenosis ranging from 50e90%, as
assessed by QCA, were analyzed. In all patients, FFR was
determined for a target coronary lesion by both IV and IC
adenosine. All patients were symptomatic with angina or
angina equivalent and had been referred for a diagnostic or
interventional cardiac catheterization. Exclusion criteria
included culprit vessel in acute coronary syndrome, acute
myocardial infarction, and atrioventricular conduction ab-
normalities in the electrocardiogram. All patients gave
informed consent to participate in the study.
2.2. Study protocol
Coronary angiography (CAG) was performed from femoral or
radial approach. Heparin was administered at the beginningof the procedure (5000 units). The heart rate and arterial
pressure were continuously monitored throughout the pro-
cedure. After CAG, a 0.014-inch pressure-recording guidewire
(PressureWire Certus, St. Jude Medical, USA) was introduced
through a guiding catheter into the coronary artery. Arterial
pressurewave damping or variation of themeasured coronary
guide pressure was avoided. The guidewire was externally
calibrated and then advanced to the distal tip of the catheter.14
At this position, it was verified that both the catheter and the
pressure wire recorded equal pressures. The pressure wire
was subsequently advanced into the coronary artery with the
pressure sensor placed beyond the lesion site. Distal coronary
and aortic pressures were measured at baseline and at
maximal hyperemia. Pressure signals were continuously
recorded and a beat-to-beat analysis of mean pressure was
performed automatically (RadiAnalyzer Xpress, St. Jude
Medical, USA).
2.3. Pharmacologic protocol
All patients first received multiple IC adenosine boluses,
which were then followed by IV adenosine. Incremental doses
of IC adenosine (60, 100, and 120 mg for both coronary arteries)
were administered. Each bolus was followed by a flush with
5 ml saline. Subsequent doses were given after pressure
curves returned to baseline values. Thereafter, adenosine
infusion via a large systemic vein at incremental doses of 140,
160, 180 mg/kg/min was administered until a steady-state hy-
peremia was achieved for a minimal duration of 1 min15 The
electrocardiogram was simultaneously recorded.
2.4. Calculations of pressure-derived FFR
FFR is defined as the ratio of the hyperemic flow in a stenotic
artery to the hyperemic flow in the same artery in the
Fig. 1 e Linear regression analysis of FFR measurements performed with intracoronary (IC) (dependent variable) and
intravenous (IV) 9 independent variable adenosine.
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expressesmaximumhyperemic blood flow in a stenotic vessel
as a fractionofnormalmaximalbloodflow in that vessel. FFR is
calculated from intracoronary and aortic pressure measure-
ments obtained during maximal hyperemia by the following
equation: FFR ¼ PdPv/PaPv, or FFRyPd/Pa (if Pv is negligible),
where Pa is the mean proximal coronary pressure, Pd is the
mean distal coronary pressure, and Pv is the mean central
venous pressure. FFR measurement was done with IC adeno-
sine at incremental doses. The valueswere taken atmaximum
hyperemia. This was compared with IV adenosine at sequen-
tially increasingdoses tillmaximumhyperemiawasproduced.2.5. Statistical analysis
Data are presented as mean  SD. Student paired t test was
used to compare FFR values after different hyperemicFig. 2 e BlandeAltman agreement between 2 sets of measureme
(IC) and intravenous (IV) adenosine plotted against mean.responses for IV and IC adenosine. Linear regression was
calculated for FFR data derived from both hyperemic stimuli,
and nonlinear regression was used for the relation of percent
stenosis to the FFR. The mean  SD of the signed differences
between measurements of FFR with intravenous and intra-
coronary adenosine was used as an index of agreement be-
tween measurements. Results were considered statistically
significant at p  0.05.3. Results
3.1. Patient characteristics
A total of 50 patients with 56 lesions were included in the
analysis. Baseline demographic data is provided in Table 1.
Procedural success was 100% for crossing the target lesionnts. Difference between measurements with intracoronary
Table 2 e Hemodynamic data for intravenous and intracoronary adenosine.
IC adenosine
(mean  SD)
IV adenosine
(mean  SD)
p value
DHR (beats/min) 0.8  3.4 5  5.6 <0.001
DBP systolic (mmHg) 3.8  7.9 15.6  16.3 <0.001
DBP diastolic (mmHg) 3.4  7.0 9.6  6.8 <0.001
DBP mean (mmHg) 3.2  5.1 10  12.8 <0.001
IV, Intravenous; IC, intracoronary; DHR, difference in heart rate; DBP, difference in arterial blood pressure.
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complication. Mean percent stenosis was 63.9  13.1%.
3.2. IC versus IV adenosine for FFR measurements
The mean FFR was 0.832  0.0707 SD with IC adenosine and it
was 0.831  0.738 SD with IV adenosine. No statistically sig-
nificant difference was detected between the 2 routes of
administration. There was a strong and linear correlation
between IC administered adenosine (as the dependent vari-
able) and IV adenosine (as the independent variable) R¼ 0.964,
y ¼ 0.065 þ 0.923x; p < 0.001 (Fig. 1). The agreement between
the 2 sets of measurements was similarly good, with a mean
difference of 0.001 and an SD of 0.0197 (Fig. 2). A random
scatter in both directions of FFRmeasurements was, however,
notedwith 2 (3.6%) lesions FFRwith IC adenosinewas0.05 as
compared to IV adenosine employing a suboptimal response
in these patients.
Changes in heart rate and blood pressure during IC and IV
adenosine administration are presented in Table 2. IV aden-
osine administration caused a significantly higher increase in
heart rate and decrease in arterial pressure than did IC
adenosine. Several systemic adverse effects (Table 3) were
observed during IV adenosine administration, whereas IC
boluses elicited an asymptomatic transient atrioventricular
block in as many as 11% of patients.4. Discussion
Physiologic lesion assessment is a reliable method for
assessing stenosis severity and a better indicator for the ne-
cessity of interventions than angiography alone.1 FFR has
several advantages in clinical practice, this measure is inde-
pendent of hemodynamic variation, has an unequivocal
normal value of 1.0 for each vessel, and has an ischemicTable 3 e Adverse effects of different dosages and routes
of administration of adenosine of determination of FFR.
60 mg, IC 100 mg, IC 120 mg, IC IV
Chest tightness 0 0 0 12 (21%)
Dyspnea 0 0 0 3 (5%)
Nausea 0 0 0 4 (7%)
A-V blocks 5 (9%) 6 (11%) 6 (11%) 4 (7%)
IC, intracoronary adenosine; IV, intravenous adenosine.threshold value of 0.80 tightly related to non-invasive
indexes of inducible ischemia.4,13,14 However, even for FFR
calculation, it is critical to achieve a maximal decrease in
myocardial resistance for an accurate estimate of its value.
With submaximal hyperemia, FFR will be artificially high, and
therefore, it underestimates the functional severity of the
lesion. The utility of this method in clinical decision making
for selecting the vessel needing PCI in borderline lesions has
been clearly demonstrated in the recently published FAME
and FAME 2 studies.4,5 FAME and FAME 2 used fixed dose IV
adenosine, 140 mg/kg/min dose. In our study of comparison
between IC and IV adenosine, we have used incremental
doses in both methods to achieve hyperemia. The aim of our
study was to see if maximum hyperemia can be achieved by
bothmethods and to see its effects on FFR asmeasured during
PCI procedures.
Adenosine, mainly IV, has been validated for FFR mea-
surements. Several observations have raised doubts about the
ability of the IC adenosine boluses to achieve maximal hy-
peremia in all patients and a recent study by Leone et al has
demonstrated comparable hyperemia with IC adenosine to IV
adenosine at higher doses (600 mg) currently suggested.9,11,12
In this study, IC bolus administration of adenosine in a dose
of 60e120 mg produced equivalent maximal hyperemia to an
IV infusion with incremental doses. The calculation of FFR in
the majority of patients, a random scatter was observed in
both directions of FFR measurements. However, in 2 (3.6%)
lesions FFR with IC adenosine was 0.05 as compared to IV
adenosine employing a suboptimal response in these patients
which was statistically nonsignificant. The explanation for
this comparable hyperemic response between two groups
could be, adequate dosing of the drug, or meticulous delivery
technique of the IC drug, or may be superior hyperemic
response in the Indian ethnic population.
Administration of IV adenosine in the catheterization
laboratory has several disadvantages compared with IC bo-
luses. The latter is much easier to administer, has an
extremely rapid onset of action, and has a short half-life,
which makes it ideal for repetitive measurements. Further-
more, IC adenosine is associated with fewer systemic adverse
effects and since, only a small fraction of the IV dosage is
needed for the IC bolus it is significantly more cost effective.
Nomajor adverse events related to the IC drug administration
have been reported from multiple trials measuring FFR.17
However, IV adenosine achieves a more complete and stable
vasodilatation and is more convenient for the assessment of
tandem lesions, diffuse coronary artery disease and ostial le-
sions where a pull back of the pressure wire is needed.
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This study suggests that IC adenosine is equivalent to IV
infusion for achievement of maximal hyperemia and the
determination of FFR in short segment or focal lesions. The
administration of IC adenosine is easy to use, cost effective,
safe and associated with fewer systemic events.Conflicts of interest
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